Division News

Steve M. Taylor, MD, MPH, associate professor of medicine, Division of Infectious Diseases, and associate research professor of global health, is taking on the new position of Associate Vice Chair for Global Health Research in the Department of Medicine effective March 1, 2022.

Robert M. Califf, MD, Duke University adjunct professor of medicine (cardiology) and former director of the Duke Clinical Research Institute (DCRI), has been confirmed as commissioner for the U.S. Food and Drug Administration following a vote by the Senate today. Califf’s appointment to the position will mark his second time heading the agency, which he also led during the final year of former President Barack Obama’s administration.

Duke University School of Medicine was awarded more than $608 million in federal funding from the National Institutes of Health (NIH) in 2021, ranking third nationally among academic medical centers, up from 10th last year, according to the Blue Ridge Institute for Medical Research.

The Department of Medicine's award of that total was $174,530,472. 

ALICE – Academic Leadership, Innovation, and Collaborative Engagement –  is year-long a leadership development opportunity for mid-career women faculty in the School of Medicine.

Sponsored Research

Andrew Armstrong of Medical Oncology has received an award from the Movember Foundation for a project entitled "International Retrospective Collaborative Analysis of the Impact of Ablative Therapy Directed to the Local Tumor and/or Metastases for Patients with Oligometastatic Prostate Cancer¿." TBD

Vance Fowler of Infectious Diseases has received an award from the National Institutes of Health for a project entitled "HLA Fine Mapping to Elucidate S. aureus Susceptibility - R01." Total funding will be $3,757,863.

Sponsored Research 

Melissa Daubert of Cardiology has received an award from the National Institutes of Health for a project entitled "Coronary Artery Calcium in the PRagmatic EValuation of evENTs And Benefits of Lipid lowering in the Elderly: CAC PREVENTABLE Ancillary Study." Total funding will be $7,892,380.

The October 12, 2021, session of Duke Medicine LEADS featured Adam DeVore, MD; Omar Mohamedaly, MD; Stephen J. Greene, MD; and Lindsay King, MD, presenting "Perspectives and Innovations in Multidisciplinary Care at Duke."

The October 05, 2021, session of Duke Medicine LEADS was presented by Joshua Parsons, MD, Ryan Anderson, MD, Vanessa Blumer, MD, Cary Ward, MD,PhD, and Arthur Baker, MD, on "A Challenging Case of Endocarditis— Multi-Disciplinary Approach is an Achievable Chimera."

Congratulations to the following faculty members for their recent promotion in the Department of Medicine. The following changes were approved during the August 20, 2021, and September 24, 2021, Board of Trustees meetings.

The Diversity, Equity, Inclusion, and Anti-Racism Committee (DEIAR) announced the individuals selected to become the inaugural Vice Chiefs for Diversity, Equity, and Inclusion (VCDEI) for each division within the department of medicine. These individuals are all wonderful thoughtful leaders who have shown a commitment to improving DEI within the department.